Nureca Q3 FY26 – Strong Turnaround with Profitable Growth

Nureca delivered a powerful turnaround in the December 2025 quarter, registering healthy revenue growth and a decisive shift from losses to profitability, driven by improving operations and better cost efficiency. • Sales: ↑ 50% YoY to ₹39.6 crore (vs ₹26.5 crore in Dec 2024) • EBIDT: ↑ 181% YoY to ₹3.25 crore (vs -₹4.01 crore) • Net Profit: ↑ 233% YoY to ₹3.73 crore (vs -₹2.80 crore) • EPS: ↑ 240% YoY to ₹3.91 (vs -₹2.80) At a price of ₹312, market cap ₹298 crore, and PE 28.0, Nureca reflects a clear earnings revival after a challenging phase. The shift from losses to consistent profits highlights operational discipline and improving business traction, setting the foundation for sustained growth in the coming quarters.